Founded on the belief that a better world begins with a better you.
IntellxxDNA is a genomics intelligence services company, created to individualize the practice of medicine by empowering functional and integrative clinicians with molecular-level insight into each patient, realizing evidence-based, precision treatment — and nurturing a new level of healing and care for the patient, for society and for our planet.
Founded by Carol Bilich and Sharon Hausman-Cohen, MD, IntellxxDNA grew out of a shared commitment to understanding complex patient care more deeply and making emerging science genuinely useful in clinical practice.
Before founding IntellxxDNA, Carol Bilich and Sharon Hausman-Cohen, MD were each independently conducting in-depth research to better understand complex patient care for their patients. As genomic science became increasingly available, genomics became an important part of that work for both of them.
When they came together to build Resilient Health, they knew they wanted genomics to be part of the way they approached patient care. What they could not find was a tool that brought the science together in a way that was comprehensive, clinically relevant, and actionable. So they began doing the work themselves, going well beyond isolated genetic variants to examine the relationships among genes, gene-gene interactions, pathways, mechanisms, and the broader clinical picture.
That work ultimately became IntellxxDNA.
Dr. Sharon Hausman-Cohen
Co-Founder, Chief Science Officer, & Medical Director
Dr. Sharon Hausman-Cohen is Co-Founder, Chief Science Officer, and Medical Director of IntellxxDNA®. She has been using genomics for over a decade to deliver personalized medicine and help her patients achieve optimal health and wellness. READ FULL BIO
Carol Bilich
Co-Founder and CEO
Carol Bilich is Co-Founder and CEO of IntellxxDNA®. For more than 25 years, she has worked alongside physicians on complex patient cases, contributing patient insights, conducting individualized research, and bringing together emerging science and clinical questions to help inform care. Her role has often been that of a systems architect, identifying relationships across complex information and helping translate them into structures that can be used in clinical practice. READ FULL BIO
Connie Trotter
Executive Advisor
Over the span of a 30-year career in healthcare operations, Connie Trotter has brought clarity, efficiency and problem-solving to some of the most successful practices in Austin, Texas, including concierge medicine, family medicine, dialysis clinics and cardiology. In addition to bringing her critical operational and managerial responsibilities to IntellxxDNA, our clinician clients rely on Connie for her experience and insight in successfully deploying our decision support tool in their practices.
Sue Koch
Director of Operations
Sue brings over 25 years of experience in business operations, digital marketing, and organizational leadership across a wide array of industries from real estate to healthcare, with a focus on SaaS. At IntellxxDNA, Sue leads operational strategy, process optimization, and cross-functional collaboration to ensure alignment between clinical, technical, and business teams. Her career spans executive leadership and agency roles where she’s built scalable systems and implemented data-driven frameworks that improve efficiency and drive growth. Sue’s passion for innovation, integrity, and human-centered leadership supports IntellxxDNA’s mission to empower clinicians with ethical, research-based genomic tools that transform patient care.
Mike Sheridan
Director of Growth
Mike manages the IntellxxDNA go-to-market initiatives to help meet the company goal of making genomics widely available to patients suffering from chronic disease. Mike brings a wealth of sales and marketing leadership experience from start-ups like Inbox Health to mid-size enterprises like Aspect Software applying a strategic, customer-centric approach to deliver sustainable growth. With an eye towards using data derived insights, he employs a collaborative style in working with customers, internal teams, and channel partners to remove barriers, implement change, and grow teams.
Mike holds a Master of Science in Computer Science from Depaul University.
Todd McConnell
Chief Technology Officer
Todd has almost 30 years working with commercial, government, and healthcare agencies providing support with their technology and business needs. He loves working with customers and helping them watch their visions converted into working successful IT systems. For the past 8 years he has been focused on melding technology and genetics to design the IntellxxDNA system. Todd joins the IntellxxDNA team to further support this team of highly innovative individuals. Todd is excited to join the IntellxxDNA team as we continue to expand and break new ground advancing genetic research and bringing the practical application to people around the world.
Andrea Sanchez
Marketing Associate
Andrea is on our marketing team at IntellxxDNA, where she is responsible for establishing a meaningful connection with our providers. She works heavily with our CEO in developing and maintaining our online education platform, connecting the dots for us with everything related to workshop development, IT, and updating the world about what we’re up to! She is a creative and talented artist as well as a film editor. Without her, Genomics University would not be possible. As a former part of the clinical staff at Dr. Hausman-Cohen’s practice, Resilient Health, Andrea has developed a unique perspective on genomics and patient care. A self-described curious thinker, Andrea is committed to the growth and innovation of IntellxxDNA. She is currently most passionate about the work she is doing to grow IntellxxDNA’s presence in the field of personalized medicine.
Andrea holds a Bachelor of Science from the University of Texas.
Melissa Salazar
Customer Experience Associate
Melissa is a valued member of the Support Team at IntellxxDNA®, where she assists with provider inquiries, helps resolve technical challenges, and brings organization and clarity to the customer service experience.
With a naturally compassionate outlook and an honest approach to life, Melissa is dedicated to serving others in a meaningful way. Originally trained as a sign language interpreter, she’s embraced the opportunity to expand her knowledge in the field of genomics and finds great joy in supporting IntellxxDNA® with their efforts to identify and meet the needs of both clinicians and their patients.
Wendy Gans, MS, RD
Customer Success Manager
Wendy Gans is a Clinical Account Manager at IntellxxDNA, where she works closely with physicians and healthcare teams to integrate advanced genomic insights into patient care. With a background as a functional medicine RD and a talent for simplifying complex concepts, Wendy provides personalized onboarding, clinical training, and ongoing support to ensure providers feel confident and equipped in using IntellxxDNA’s tools. She is committed to helping practices deliver more precise, informed care—especially for patients with chronic or complex conditions—by turning genomic data into meaningful, actionable strategies.
Hannah Finnegan
Medical Research Associate
Hannah Finnegan earned her degree in Molecular Biosciences with a minor in Business from the University of Texas at Austin in 2025. During her time at UT, she conducted research in Dell Medical School’s human research labs and led a pilot mental health initiative within the College of Natural Sciences. Drawn to the company’s mission and values, Hannah joined the R&D team as a Medical Research Associate, where she contributes to advancing innovative scientific solutions with real-world impact.
IntellxxDNA routinely consults with MDs and PhDs from around the world in an effort to continually provide clinically useful genomic intelligence. We are honored to be among these valued advisors.
Arwen Podesta, M.D.
Dr. Podesta is a board certified psychiatrist and nationally recognized expert in the field of addiction. Her background in biochemistry and genetics has positioned her to be an ideal consultant to IntellxxDNA as we developed our Mental Wellness Report. She is currently involved in research regarding addiction and the role of NAD as well as serving as a psychiatrist with additional specialties in integrative and forensic medicine. In addition to helping to connect potential interventions and genomic mechanisms in our Addiction panel, she has served as an educator as part of our IntellxxDNA trainings.
Robert Sheeler, M.D.
Dr. Sheeler is a global thought leader in the world of both Integrative and Functional Medicine. After 20 years in numerous leadership positions including faculty, Clinical Practice Chair for the Department of Family Medicine and the Family Medicine Clerkship Director at the Mayo Clinic Medical School, Dr. Sheeler went into private practice so that he could be truly at the forefront of medicine. He teaches Functional Medicine across the globe and has been an early adopter of genomics, using IntellxxDNA since its inception. His insight, feedback, beta testing and recommendations for interventions during the development process of our reports and beyond has helped us create one of the most highly respected genomic products in the country.
Angela O’Neil, M.D.
Dr. Angela O’Neil, who is Board Certified in Family Medicine and Integrative Medicine and who is a Certified Functional Medicine Practitioner, was previously the Assistant Dean and Assistant Professor of the Mayo Medical School. Her focus in Child and Adolescent Health as well as Women’s health has offered IntellxxDNA insight as she beta tested our medical overview report. Dr. O’Neil’s feedback has also helped us as we move forward to address concerns of all ages including topics such as ADHD, other topics contributing to mental wellness and future development on reports designed for women’s health. Dr. O’Neil has been using IntellxxDNA since its inception.
Heather Way, PhD.
Dr. Heather Way is the head of the Australian Centre for Genomic Analysis. As a specialist in Autism, genomics and nutrition, Dr. Way has helped almost 1000 children dramatically improve their quality of life, often going from non-verbal to being mainstreamed. Dr. Way was the inspiration for our Neurodevelopmental Genomics Report and has been instrumental in the research and development of this report which is geared toward helping individuals with Autism and other neurodevelopmental disorders. Her love and support as well as her tremendous knowledge has helped IntellxxDNA become the first Clinical Decision Support tool that has a report designed specifically for identifying modifiable contributing factors to neurodevelopmental conditions.
Request a Clinician Account
Available only to licensed health care professionals, your IntellxxDNA account will be your dedicated portal to your patients’ reporting, training and support materials and other information of assistance.
Dr. Sharon Hausman-Cohen
Co-Founder, Chief Science Officer, & Medical Director
Dr. Sharon Hausman-Cohen is Co-Founder, Chief Science Officer, and Medical Director of IntellxxDNA®. She has been using genomics for over a decade to deliver personalized medicine and help her patients achieve optimal health and wellness.
Before IntellxxDNA®, Sharon was conducting in-depth research to better understand complex patient care, including genomics as the science became available. As a physician, researcher, and clinician advocate, she also recognized that inaccuracies in genomic information and the complexity of the science could make it difficult for clinicians to use effectively.
When Sharon and Carol Bilich came together to build Resilient Health, they knew they wanted genomics to be part of their approach to patient care. Both had already been researching genomics independently, but they could not find a tool that provided the breadth and depth of information they needed in a way that was comprehensive, clinically relevant, and actionable. They wanted to look beyond individual variants and risk to understand relationships among genes, pathways, biological mechanisms, environmental influences, and other factors that could contribute to an individual patient’s health. Together, they continued the research and began developing the methodologies and tools that ultimately became IntellxxDNA®.
In addition to being a well-regarded physician and researcher, Dr. Hausman-Cohen is a sought-after speaker and educator on genomics, personalized medicine, and integrative medicine. She received both her master’s and medical degrees from Harvard Medical School. Board-certified in Family Medicine, she is a Fellow of the American Board of Integrative and Holistic Medicine and holds additional board certification in Integrative Medicine through the American Board of Physician Specialties. She has been practicing Full Spectrum Family Medicine and Integrative Medicine for more than 25 years.
Carol Bilich
Co-Founder and CEO
Carol Bilich is Co-Founder and CEO of IntellxxDNA®. For more than 25 years, she has worked alongside physicians on complex patient cases, contributing observations from her work with patients and conducting extensive individualized research to help inform their clinical thinking.
Her work was never limited to what she could observe directly with a patient. Many of the people she worked with had complex concerns that were not being fully explained or resolved through traditional approaches, leading Carol to spend years reading the medical literature, researching individual cases, looking across disciplines, and exploring what additional information might be relevant to their care.
Carol’s role has often been that of a systems architect, bringing together patient observations, medical research, biology, emerging science, and clinical questions to identify patterns and relationships that may not be apparent when each piece is considered in isolation. As genomic science became increasingly available, genomics became an important part of that work.
When Carol and Sharon Hausman-Cohen, MD came together to build Resilient Health, they knew they wanted genomics to be part of their approach to patient care. Both had already been researching genomics independently, but they could not find a tool that provided the breadth and depth of information they needed in a way that was comprehensive, clinically relevant, and actionable. They wanted to look beyond individual variants and risk to understand relationships among genes, pathways, biological mechanisms, environmental influences, and other factors that could contribute to an individual patient’s health. Together, they continued the research and began developing the methodologies and tools that ultimately became IntellxxDNA®.
That same systems thinking continues to shape Carol’s work at IntellxxDNA®. She remains deeply involved in the company’s research, product development, clinical applications, strategy, and overall direction, helping translate an increasingly complex body of genomic science into the structures, methodologies, and tools clinicians can use in practice.
Carol received both undergraduate and graduate degrees from the University of Texas and obtained a Certification in Business Entrepreneurship from Texas State University. She has launched three businesses, including Resilient Health, a full-spectrum concierge practice serving the greater Austin area.